Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-201178
Filing Date
2022-07-26
Accepted
2022-07-25 21:32:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d377126d425.htm 425 19708
2 GRAPHIC g377126g0726054658938.jpg GRAPHIC 36246
3 GRAPHIC g377126g0726054659157.jpg GRAPHIC 48243
  Complete submission text file 0001193125-22-201178.txt   138296
Mailing Address 5980 HORTON STREET, SUITE 105 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET, SUITE 105 EMERYVILLE CA 94608 (415) 801-8073
Zymergen Inc. (Subject) CIK: 0001645842 (see all company filings)

EIN.: 462942439 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40354 | Film No.: 221104766
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filed by) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)